RCAMU
Rothschild & Co Asset Management US Portfolio holdings
AUM
$6.58B
1-Year Return
4.5%
This Quarter Return
+1.39%
1 Year Return
-4.5%
3 Year Return
+63.72%
5 Year Return
+103.96%
10 Year Return
–
AUM
$9.24B
AUM Growth
-$130M
(-1.4%)
Cap. Flow
-$185M
Cap. Flow
% of AUM
-2%
Top 10 Holdings %
Top 10 Hldgs %
12.25%
Holding
362
New
11
Increased
110
Reduced
214
Closed
15
Top Buys
| 1 |
Kimberly-Clark
KMB
|
$44.6M |
| 2 |
KB Home
KBH
|
$33.7M |
| 3 |
Textron
TXT
|
$33.5M |
| 4 |
RH
RH
|
$33.4M |
| 5 |
CF Industries
CF
|
$30.5M |
Top Sells
| 1 |
Pfizer
PFE
|
$57.2M |
| 2 |
Essent Group
ESNT
|
$37.4M |
| 3 |
AGN
Allergan plc
AGN
|
$35.4M |
| 4 |
Emcor
EME
|
$28.5M |
| 5 |
Chevron
CVX
|
$27.2M |
Sector Composition
| 1 | Financials | 17.58% |
| 2 | Industrials | 14.5% |
| 3 | Healthcare | 12.79% |
| 4 | Technology | 11.13% |
| 5 | Consumer Discretionary | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
SPDR S&P 500 ETF Trust
SPY
$660B
| $713K | 0.01% |
2,402
-6,162
| -72% | -$1.83M |
|
|
PPBI
327
DELISTED
Pacific Premier Bancorp
PPBI
| $648K | 0.01% |
20,779
-238
| -1% | -$7.42K |
|
328
PTC Therapeutics
PTCT
$4.55B
| $647K | 0.01% |
19,140
+2,043
| +12% | +$69.1K |
|
329
Steris
STE
$24.2B
| $618K | 0.01% |
4,274
-3,146
| -42% | -$455K |
|
330
Avanos Medical
AVNS
$590M
| $616K | 0.01% |
16,448
-187
| -1% | -$7K |
|
331
Esperion Therapeutics
ESPR
$540M
| $596K | 0.01% |
16,247
-149
| -0.9% | -$5.47K |
|
332
Labcorp
LH
$23.2B
| $592K | 0.01% |
4,098
-191
| -4% | -$27.6K |
|
333
Public Service Enterprise Group
PEG
$40.5B
| $587K | 0.01% |
9,445
+2
| +0% | +$124 |
|
334
MaxLinear
MXL
$1.36B
| $584K | 0.01% |
26,073
-300
| -1% | -$6.72K |
|
335
Zoetis
ZTS
$67.9B
| $563K | 0.01% |
4,520
-228
| -5% | -$28.4K |
|
|
PETQ
336
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $549K | 0.01% |
+20,122
| New | +$549K |
|
337
Bristol-Myers Squibb
BMY
$96B
| $534K | 0.01% |
10,521
+2,015
| +24% | +$102K |
|
338
eBay
EBAY
$42.3B
| $500K | 0.01% |
12,828
-461
| -3% | -$18K |
|
339
Matador Resources
MTDR
$6.01B
| $491K | 0.01% |
29,677
-339
| -1% | -$5.61K |
|
|
RVNC
340
DELISTED
Revance Therapeutics, Inc.
RVNC
| $456K | ﹤0.01% |
35,057
+7,636
| +28% | +$99.3K |
|
341
Bank of New York Mellon
BK
$73.1B
| $455K | ﹤0.01% |
10,055
-480
| -5% | -$21.7K |
|
342
Amgen
AMGN
$153B
| $319K | ﹤0.01% |
1,650
-50
| -3% | -$9.67K |
|
343
Home Depot
HD
$417B
| $294K | ﹤0.01% |
1,269
| – | – |
|
344
Parker-Hannifin
PH
$96.1B
| $284K | ﹤0.01% |
1,573
-94,907
| -98% | -$17.1M |
|
345
Nucor
NUE
$33.8B
| $245K | ﹤0.01% |
4,808
-223
| -4% | -$11.4K |
|
346
Alphabet (Google) Class C
GOOG
$2.84T
| $244K | ﹤0.01% |
4,000
| – | – |
|
347
lululemon athletica
LULU
$19.9B
| $238K | ﹤0.01% |
1,238
| – | – |
|
348
iShares Russell 2000 Value ETF
IWN
$11.9B
| $237K | ﹤0.01% |
+1,987
| New | +$237K |
|
349
Exxon Mobil
XOM
$466B
| $217K | ﹤0.01% |
3,084
| – | – |
|
350
Adeia
ADEA
$1.69B
| – | – |
-861,761
| Closed | -$4.69M |
|